Nature Communications (Nov 2022)

Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation

  • Bartosz Mucha,
  • Shuo Qie,
  • Sagar Bajpai,
  • Vincenzo Tarallo,
  • J. Nathaniel Diehl,
  • Frank Tedeschi,
  • Gao Zhou,
  • Zhaofeng Gao,
  • Samuel Flashner,
  • Andres J. Klein-Szanto,
  • Hanina Hibshoosh,
  • Shimonosono Masataka,
  • Olga S. Chajewski,
  • Ireneusz Majsterek,
  • Dariusz Pytel,
  • Maria Hatzoglou,
  • Channing J. Der,
  • Hiroshi Nakagawa,
  • Adam J. Bass,
  • Kwok-Kin Wong,
  • Serge Y. Fuchs,
  • Anil K. Rustgi,
  • Eckhard Jankowsky,
  • J. Alan Diehl

DOI
https://doi.org/10.1038/s41467-022-34402-6
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 18

Abstract

Read online

Cytoplasmic accumulation of RNA binding protein, hnRNPK in cancer cells is associated with poor prognosis. Here the authors show that SCFFbxo4 E3 ubiquitin ligase-mediated polyubiquitylation of hnRNPK restricts c-Myc translation and limits cancer progression.